Road shows mean nothing. Publicity stunts. CTAD is important...according to board. No price movement bodes well? (If someone had taken a poll on this board two or three weeks ago asking what the share price would be around Nov.1, I am sure most posters would have said higher than it is now. Disconcerting, if you ask me. Missling will probably repeat the same bs. What we need is unequivocal efficacy data. Does it work?
Anavex uses "The Trout Group" for Investor relation advice and strategy. The Trout Group is the leading global investor relations and strategic advisory firm servicing the life sciences industry. I do not know how long they have been using them but have wondered who is updating the site?